Valeant Pharma (VRX) Provides Details of Michael Pearson Separation Agreement; $83,333/Mth Through End of 2016
Tweet Send to a Friend
Valeant Pharma (NYSE: VRX) provided details of its J. Michael Pearson Separation Agreement:Valeant Pharmaceuticals International, Inc. (the “Company”) and Mr ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
